Nomination Committee appointed for 2010-2011
Medivir AB (OMX: MVIR), a research-based specialty pharmaceutical company focused on infectious diseases, today announces that a new Nomination Committee has been appointed consisting of; Maria Wikström, Länsförsäkringar Fondförvaltning AB, Bo Öberg, representing A shareholders, Frank Larsson, Handelsbanken Kapitalförvaltning and Göran Pettersson, Chairman of the Board. Pursuant to an AGM resolution, the Nomination Committee shall consist of the Chairman of the Board and three shareholder representatives, for which the three largest shareholders as of the end of the third quarter 2010